Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome and panel-based approaches, three-part reports for rapid results reporting, and the clinical utility of the Neurology Exome’s tailored approach compared to other tests currently on the market.
from The Medical News http://ift.tt/1GYojCk
from The Medical News http://ift.tt/1GYojCk
No comments:
Post a Comment